<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04329364</url>
  </required_header>
  <id_info>
    <org_study_id>2019/2930</org_study_id>
    <nct_id>NCT04329364</nct_id>
  </id_info>
  <brief_title>RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty</brief_title>
  <acronym>COHLAH</acronym>
  <official_title>A Randomised Controlled Trial Comparing Conventional Open Haemorrhoidectomy and Laser Haemorrhoidoplasty in the Treatment of Symptomatic Haemorrhoids: COHLAH Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sengkang General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biolitec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sengkang General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Haemorrhoids or piles are the most common colorectal condition in the local population.
      Patients often present with bleeding with bowel movement or anal discomfort, both of which
      causes significant anxiety and stress. For symptomatic sizeable piles, the treatment of
      choice still remains the conventional open excision (COH). However, this technique carries
      with it a significant risk of bleeding and pain immediately after the operation, leading to
      some period of discomfort for the patients. The laser haemorrhoidoplasty procedure (LAH) has
      been shown in preliminary studies to have less pain, and less complications compared to COH.
      This study aims to directly compare these two techniques in a local Asian population.

      The investigators would be conducting a single-centre RCT simultaneously comparing the
      conventional open Milligan-Morgan haemorrhoidectomy (COH) and the laser haemorrhoidoplasty
      procedure (LAH) for the treatment of symptomatic grade ll-lV haemorrhoids. Primary outcomes
      will be post-operative pain while secondary outcomes include post-operative bleeding,
      readmission and/or reoperations, haemorrhoid-related quality of life (QoL) results and
      recurrence of symptoms up to a year post procedure
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The investigators would be conducting a single-centre RCT simultaneously comparing the conventional open Milligan-Morgan haemorrhoidectomy (COH) and the laser haemorrhoidoplasty procedure (LAH) for the treatment of symptomatic grade ll-lV haemorrhoids.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Allocation is provided in a concealed opaque enveloped that is provided by the research administrator on the day of the operation. Thus, the participant is blinded to the procedure. There will also be no cross-over from one study arm to another.
An independent research administrator, not part of the randomisation process, will also contact the patient 3 months and 1 year after the procedure as mentioned above.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores</measure>
    <time_frame>10 days from op</time_frame>
    <description>Daily visual analogue pain scale in the first 10 days after surgery. A score of 10 being the worst pain experienced and 1 being no pain experienced.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative duration</measure>
    <time_frame>during operation</time_frame>
    <description>duration of operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op bleeding</measure>
    <time_frame>10 days from operation</time_frame>
    <description>incidence of bleeding post op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readmission</measure>
    <time_frame>3 months</time_frame>
    <description>readmission due to complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence</measure>
    <time_frame>1 year post operation</time_frame>
    <description>recurrence of haemorrhoids or symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life measures</measure>
    <time_frame>10 days, 1 month, 3 months and 1 year post operation</time_frame>
    <description>2 validated questionnaires will be used ([patient self reported symptoms of haemorrhoids] Nystrom, et al. and [standardised haemorrhoidectomy QOL survey] Chew, et al)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>Laser Haemorrhoidoplasty (LAH)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treatment that we would like to study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Open Haemorrhoidectomy (COH)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>gold standard treatment as comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Laser Haemorrhoidoplasty (LAH)</intervention_name>
    <description>Using a laser diode to cause coagulative necrosis to the haemorrhoidal cushion</description>
    <arm_group_label>Laser Haemorrhoidoplasty (LAH)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open milligan-morgan conventional haemorrhoidectomy</intervention_name>
    <description>conventional excisional haemorrhoidectomy</description>
    <arm_group_label>Conventional Open Haemorrhoidectomy (COH)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. between 21-70 years old

          2. presents with symptomatic haemorrhoids as evident from clinical assessment

          3. never had any haemorrhoid-related operations performed on them before

          4. fit for general anaesthesia

          5. able to give informed consent

          6. willing to be randomized

          7. willing to fill in post-operative questionnaires and be compliant to follow up

        Exclusion Criteria:

          1. Are pregnant

          2. Are prisoners

          3. Intellectually, mentally or emotionally deemed not able to provide an informed consent
             and/or are unable to fill up the post-procedure questionnaires/VAS score

          4. Have had previous haemorrhoid procedural treatment before (except Rubber Band
             Ligation)

          5. Declined endoscopic evaluation

          6. Are on anti-platelets and/or anti-coagulation

          7. Have history of thrombophilia

          8. Are on steroids

          9. Have haemorrhoids which are incidentally found on endoscopy/clinical examination but
             are asymptomatic from it
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fung Joon Foo</last_name>
    <phone>+65 6930 5354</phone>
    <email>foo.fung.joon@singhealth.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fung Joon Foo</last_name>
    <phone>+65 6930 6000</phone>
    <email>foo.fung.joon@singhealth.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sengkang General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>544886</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fung Joon Foo</last_name>
      <phone>+65 6930 5354</phone>
      <email>foo.fung.joon@singhealth.com.sg</email>
    </contact>
    <investigator>
      <last_name>Frederick H Koh, FRCSEd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Min-Hoe Chew, FRCSEd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Winson Tan, FRCSEd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sharmini Sivarajah, FRCSEd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonard Ho, FRCSEd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fung Joon Foo, FRCSEd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2020</study_first_posted>
  <last_update_submitted>March 29, 2020</last_update_submitted>
  <last_update_submitted_qc>March 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sengkang General Hospital</investigator_affiliation>
    <investigator_full_name>Koh Hong Xiang Frederick</investigator_full_name>
    <investigator_title>Senior Staff Registrar, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>haemorrhoid</keyword>
  <keyword>laser</keyword>
  <keyword>haemorrhoidectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>country's personal data protection Act restrictions clearance</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 7, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04329364/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 29, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04329364/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

